BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37946197)

  • 1. Pharmacological inhibition of the cysteine protease cathepsin C improves graft function after heart transplantation in rats.
    Liu B; Korkmaz B; Kraft P; Mayer T; Sayour AA; Grundl MA; Domain R; Karck M; Szabó G; Korkmaz-Icöz S
    J Transl Med; 2023 Nov; 21(1):799. PubMed ID: 37946197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preservation solution Custodiol containing human alpha-1-antitrypsin improves graft recovery after prolonged cold ischemic storage in a rat model of heart transplantation.
    Korkmaz-Icöz S; Abulizi S; Li K; Korkmaz B; Georgevici AI; Sayour AA; Loganathan S; Canoglu H; Karck M; Szabó G
    Front Immunol; 2023; 14():1155343. PubMed ID: 37426668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-octanoyl dopamine is superior to dopamine in protecting graft contractile function when administered to the heart transplant recipients from brain-dead donors.
    Loganathan S; Guo Y; Jiang W; Radovits T; Ruppert M; Sayour AA; Brune M; Brlecic P; Gude P; Georgevici AI; Yard B; Karck M; Korkmaz-Icöz S; Szabó G
    Pharmacol Res; 2019 Dec; 150():104503. PubMed ID: 31629091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term effects of brain death on post-transplant graft function in a rodent model.
    Li S; Korkmaz S; Loganathan S; Radovits T; Hegedűs P; Karck M; Szabó G
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):379-86. PubMed ID: 25505342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BI 1291583: a novel selective inhibitor of cathepsin C with superior in vivo profile for the treatment of bronchiectasis.
    Kreideweiss S; Schänzle G; Schnapp G; Vintonyak V; Grundl MA
    Inflamm Res; 2023 Aug; 72(8):1709-1717. PubMed ID: 37542002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methane supplementation improves graft function in experimental heart transplantation.
    Benke K; Jász DK; Szilágyi ÁL; Baráth B; Tuboly E; Márton AR; Varga P; Mohácsi Á; Szabó A; Széll Z; Ruppert M; Radovits T; Szabó G; Merkely B; Hartmann P; Boros M
    J Heart Lung Transplant; 2021 Mar; 40(3):183-192. PubMed ID: 33277170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of soluble guanylate cyclase improves donor organ function in rat heart transplantation.
    Benke K; Németh BT; Sayour AA; Stark KA; Oláh A; Ruppert M; Szabó G; Korkmaz-Icöz S; Horváth EM; Benkő R; Hartyánszky I; Szabolcs Z; Merkely B; Radovits T
    Sci Rep; 2020 Mar; 10(1):5358. PubMed ID: 32210293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
    Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
    Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyloxalylglycine treatment of brain-dead donor rats improves both donor and graft left ventricular function after heart transplantation.
    Hegedűs P; Li S; Korkmaz-Icöz S; Radovits T; Mayer T; Al Said S; Brlecic P; Karck M; Merkely B; Szabó G
    J Heart Lung Transplant; 2016 Jan; 35(1):99-107. PubMed ID: 26255815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothermic perfusion of donor heart with a preservation solution supplemented by mesenchymal stem cells.
    Korkmaz-Icöz S; Li S; Hüttner R; Ruppert M; Radovits T; Loganathan S; Sayour AA; Brlecic P; Lasitschka F; Karck M; Szabó G
    J Heart Lung Transplant; 2019 Mar; 38(3):315-326. PubMed ID: 30638838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left-ventricular hypertrophy in 18-month-old donor rat hearts was not associated with graft dysfunction in the early phase of reperfusion after cardiac transplantation-gene expression profiling.
    Korkmaz-Icöz S; Akca D; Li S; Loganathan S; Brlecic P; Ruppert M; Sayour AA; Simm A; Brune M; Radovits T; Karck M; Szabó G
    Geroscience; 2021 Aug; 43(4):1995-2013. PubMed ID: 33871784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of the Akt pathway in transplanted Type 1 diabetic hearts is associated with post-transplant graft injury.
    Korkmaz-Icöz S; Li S; Loganathan S; Radovits T; Ruppert M; Brlecic P; Sayour AA; Veres G; Fleming T; Brune M; Most P; Karck M; Szabó G
    Interact Cardiovasc Thorac Surg; 2018 Dec; 27(6):884-894. PubMed ID: 29912386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting IRE1α-JNK-c-Jun/AP-1-sEH Signaling Pathway Improves Myocardial and Coronary Endothelial Function Following Global Myocardial Ischemia/Reperfusion.
    Xue HM; Sun WT; Chen HX; He GW; Yang Q
    Int J Med Sci; 2022; 19(9):1460-1472. PubMed ID: 36035373
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonging hypothermic ischaemic cardiac and vascular storage by inhibiting the activation of the nuclear enzyme poly(adenosine diphosphate-ribose) polymerase.
    Korkmaz-Icöz S; Radovits T; Loganathan S; Li S; Ruppert M; Benke K; Brlecic P; Szabó C; Karck M; Szabó G
    Eur J Cardiothorac Surg; 2017 May; 51(5):829-835. PubMed ID: 28204209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.
    Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y
    Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
    Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
    Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation.
    Rehm SRT; Smirnova NF; Morrone C; Götzfried J; Feuchtinger A; Pedersen J; Korkmaz B; Yildirim AÖ; Jenne DE
    Sci Rep; 2019 Jul; 9(1):9925. PubMed ID: 31289357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation with hearts from donors after circulatory declaration of death: haemodynamic and biochemical parameters at procurement predict recovery following cardioplegic storage in a rat model.
    Sourdon J; Dornbierer M; Huber S; Gahl B; Carrel TP; Tevaearai HT; Longnus SL
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e87-96. PubMed ID: 23504113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor heart preservation with hypoxic-conditioned medium-derived from bone marrow mesenchymal stem cells improves cardiac function in a heart transplantation model.
    Zhou P; Liu H; Liu X; Ling X; Xiao Z; Zhu P; Zhu Y; Lu J; Zheng S
    Stem Cell Res Ther; 2021 Jan; 12(1):56. PubMed ID: 33435991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological preconditioning with gemfibrozil preserves cardiac function after heart transplantation.
    Benke K; Mátyás C; Sayour AA; Oláh A; Németh BT; Ruppert M; Szabó G; Kökény G; Horváth EM; Hartyánszky I; Szabolcs Z; Merkely B; Radovits T
    Sci Rep; 2017 Oct; 7(1):14232. PubMed ID: 29079777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.